SASTASUNDR2024-01-012024-03-31 SASTASUNDR2024-01-012024-03-31 SASTASUNDR2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member SASTASUNDR2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member SASTASUNDR2024-03-31 SASTASUNDR2024-03-31 SASTASUNDR2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SASTASUNDR2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533259 SASTASUNDR NOTLISTED Sastasundar Ventures Limited Equity 2023-04-01 2024-03-31 2024-05-30 2024-05-21 INR Lakhs Yearly 2024-05-30 15:45:00 2024-05-30 20:30:00 true Cash Flow Indirect Declaration of unmodified opinion Single segment Financial Services 2024-01-01 2024-03-31 Audited Standalone 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3196000.00 3196000.00 0.00 0.00 0.00 1439000.00 76000.00 260000.00 0.00 0.00 0.00 0.00 2145000.00 3920000.00 -724000.00 0.00 -724000.00 0.00 0.00 0.00 -724000.00 0.00 0.00 0.00 0.00 -724000.00 417000.00 -307000.00 -307000.00 0.00 318105000.00 10 -0.02 -0.02 0.00 0.00 -0.02 -0.02 0.00 0.00 0.00 1. The above Audited Financial Results for the quarter and year to date ended March 31, 2024 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 30 May, 2024. The Standalone Financial results for the year ended March 31, 2024 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulation, 2015. 2. The Company being a Core Investment Company has only one reportable business segment and operates in only one geographical segment i.e. within India. 3. During the previous year, the Company has sold its properties for Rs. 211.50 Lakhs and Profit amounting to Rs. 126.11 Lakhs had been recognised as other income in previous year results. 4. During the previous year, the Board of Directors at its meeting held on 27th March, 2023 approved a Composite Scheme of Arrangement (the Scheme) for Demerger and Amalgamation amongst Sastasundar Ventures Limited (‘Demerged Company’ or ‘Amalgamated Company’) and Microsec Resources Private Limited (“Resulting Company”) and Sastasundar Healthbuddy Limited (“Amalgamating Company”) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013 and the rules made there under, with effect from 1st April, 2023 (the Appointed Date). Upon receipt of requisite approvals of the concerned regulatory authorities, the scheme will be recognised in the financial results. As per the provisions of paragraph 3(b) of Part 1(A) of the SEBI Master Circular dated June 20, 2023, the Amalgamated company (post Amalgamation) is required to maintain pre-public shareholding of minimum 25% including QIB of Amalgamating Company. As a part of the process, the company has filed an application with Securities and Exchange Board of India (SEBI) seeking exemption from the aforesaid provision of SEBI Master Circular dated June 20, 2023, for consideration of Mitsubishi Corporation, Japan and Rohto Pharmaceuticals Company Limited, Japan, the public shareholder of Amalgamating Company as public shareholders of Amalgamated Company. We hereby inform that SEBI vide letter dated January 30, 2024 has informed the company that the competent authority has not acceded the company’s request. The Designated Stock Exchange has not granted approval to the Scheme. The Company is exploring for appropriate steps in this regard for further course of action. 5. The figure for the quarter ended 31st March, 2024 are the balancing figure between audited figure in respect of the full financial year and the unaudited published period to date reviewed figures upto the end of the third quarter 31st December, 2023 which were subjected to a limited review. 6. Previous Period/ Year figures have been re-grouped / re-classified wherever necessary. Single segment 2023-04-01 2024-03-31 Audited Standalone 25000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25000.00 11790000.00 11815000.00 0.00 0.00 0.00 5109000.00 193000.00 1046000.00 0.00 0.00 0.00 0.00 14396000.00 20744000.00 -8929000.00 0.00 -8929000.00 0.00 0.00 0.00 -8929000.00 0.00 0.00 0.00 0.00 -8929000.00 84000.00 -8845000.00 -8845000.00 0.00 318105000.00 10 -0.28 -0.28 0.00 0.00 -0.28 -0.28 0.00 0.00 0.00 Other Expenses 2145000.00 Other Expenses 14396000.00 846000.00 221000.00 0.00 0.00 0.00 0.00 2648720000.00 55573000.00 2705360000.00 0.00 2346000.00 0.00 0.00 0.00 20248000.00 0.00 0.00 0.00 0.00 1313000.00 23907000.00 2729267000.00 318105000.00 2407246000.00 2725351000.00 0.00 0.00 0.00 1439000.00 0.00 0.00 0.00 0.00 0.00 0.00 1512000.00 2951000.00 0.00 0.00 0.00 965000.00 965000.00 2729267000.00 Remeasurement gain/ (loss) on defined benefit plans (net of tax) 417000.00 Remeasurement gain/ (loss) on defined benefit plans (net of tax) 84000.00 417000.00 84000.00 0.00 0.00 0.00 0.00 417000.00 84000.00 0.00 0.00 0.00 0.00 -139000.00 0.00 0.00 509000.00 0.00 -566000.00 0.00 0.00 664000.00 1046000.00 0.00 130000.00 0.00 -452000.00 0.00 0.00 0.00 3789000.00 0.00 -735000.00 0.00 0.00 0.00 4000.00 0.00 -3328000.00 -12257000.00 0.00 0.00 0.00 -189000.00 0.00 -12068000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 26000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 56369000.00 45900000.00 0.00 0.00 0.00 0.00 0.00 495000.00 0.00 0.00 0.00 10938000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1130000.00 0.00 -1130000.00 1976000.00 846000.00